Tag: ISC 2022
Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas
A new strategy using telehealth to monitor blood pressure at home for several months immediately after a stroke had a positive impact on patient engagement and blood...
New technology enables option for neurosurgeons to avoid pinning patients’ heads...
Following the introduction of its BrainPath navigation probe adapter at the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA), medical device innovator NICO Corporation claims...
Children with severe stroke may fare better if treatment includes mechanical...
Serious disability is six times more likely to be the result three months after stroke among children whose large-vessel stroke was not treated with...
ISC 2022: New study finds better outcomes in patients treated at...
When comparing outcomes for acute ischaemic stroke patients treated at various levels of stroke centres, patients who received care at comprehensive stroke centres (CSC) or thrombectomy-capable...
Newer clot-busting medication may someday increase time window for stroke treatment
In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...
ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has...
Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...
NovaGuide intelligent ultrasound found to significantly improve right-to-left shunt detection
NovaSignal Corporation has announced the results of a multicentre, prospective, single-arm study indicating that the company’s autonomous NovaGuide intelligent ultrasound is three times more...
New data presented at ISC 2022 further validate real-world impact of...
Data from several new studies presented at the recent International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA) further validate the “best-in-class” sensitivity and...
Cerenovus launches Emboguard balloon guide catheter for acute ischaemic stroke
Cerenovus—a neurovascular firm that forms part of Johnson & Johnson Medical Devices Companies—has announced the launch of Emboguard, its next-generation balloon guide catheter to...
Mechanical thrombectomy shown to restore more function than medication alone following...
A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...
